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Abstract
An interpretation of the metabolic response to injury in patients with severe accidental or surgical trauma is made. In 
the last century, various authors attributed a meaning to the post-traumatic inflammatory response by using 
teleological arguments. Their interpretations of this response, not only facilitates integrating the knowledge, but also 
the flow from the bench to the bedside, which is the main objective of modern translational research. The goal of the 
current review is to correlate the metabolic changes with the three phenotypes -ischemia-reperfusion, leukocytic and 
angiogenic- that the patients express during the evolution of the systemic inflammatory response. The sequence in 
the expression of multiple metabolic systems that becomes progressively more elaborate and complex in severe 
injured patients urges for more detailed knowledge in order to establish the most adequate metabolic support 
according to the evolutive phase. Thus, clinicians must employ different treatment strategies based on the different 
metabolic phases when caring for this challenging patient population. Perhaps, the best therapeutic option would be 
to favor early hypometabolism during the ischemia-reperfusion phase, to boost the antienzymatic metabolism and to 
reduce hypermetabolism during the leukocytic phase through the early administration of enteral nutrition and the 
modulation of the acute phase response. Lastly, the early epithelial regeneration of the injured organs and tissues by 
means of an oxidative metabolism would reduce the fibrotic sequelae in these severely injured patients.
Introduction
Inflammation is a complex, multiscale biologic response
to stress that is also required for repair and regeneration
after injury [1]. Particularly, in patients with severe acci-
dental or surgical trauma the inflammatory response
shows its multifaceted and actually soundless capacity [2-
5].
I n  t h e  l a s t  c e n t u r y ,  D a v i d  P .  C u t h b e r t s o n  [ 6 ] ,  H a n s
Selye [7] and Francis D. Moore [8] attributed a meaning
to the post-traumatic inflammatory response accordingly
with previous discoveries and the knowledge of the time.
By using teleological arguments, these extraordinary
authors tried to make inroads into the understanding of
the metabolic response of the body to injury [6-8]. Their
interpretations of this response, not only facilitates inte-
grating the knowledge, but also the flow from the bench
to the bedside, which is the main objective of modern
translational research [1,9,10].
Thus, this would justify the contribution of new inter-
p r e t a t i o n s  o f  t h e  m e t a b o l i c  r e s p o n s e  t o  i n j u r y ,  i n  a n
attempt to facilitate incorporating the newly acquired
knowledge of these conditions, in addition to other
apparently disparate diseases that have common biologi-
cal pathways and therapeutic approaches [9].
Trophic mechanisms linked to the evolution of the 
Inflammatory Response
We have formulated the hypothesis that both acute local
and systemic inflammatory response to injury are based
on the successive pathologic functional predominance of
three systems referred to as the nervous, inmune and
endocrine systems. These names are based on the idea
that the final and prevalent functions traditionally attrib-
uted to these systems may represent the consecutive
response phases to stress [11-13].
This hypothesis implies that the successive pathophysi-
ological mechanisms developed by the body when under-
going inflammation are considered increasingly complex
trophic functional systems for using oxygen [12,13].
The first or immediate phase hase been referred to as
the nervous phase, because the sensory (pain and analge-
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sia) and motor (contraction and relaxation) alterations
respond to the injury. The nervous or immediate func-
tional system presents ischemia-revascularization and
edema, which favor nutrition by diffusion through the tis-
sues and organs. This trophic mechanism has a low
energy requirement that does not require oxygen (isch-
emia) or in which the oxygen is not correctly used, with
the subsequent development of oxidative and nitrosative
stress. In this phase, while the progression of interstitial
edema increases the space between the parenchymal cells
and the capillaries, the lymphatic circulation is simulta-
neously activated (circulatory switch). Thus, tissues and
organs adopt an ischemia-revascularization phenotype
[12,13] (Figure 1).
In the following immune or intermediate phase of the
inflammatory response, the tissues and organs which
have suffered ischemia-reperfusion are infiltrated by
inflammatory cells and bacteria. Symbiosis of these cells
and bacteria for extracellular digestion by enzyme release
(fermentation) and by intracellular digestion (phagocyto-
s i s )  c o u l d  b e  a s s o c i a t e d  w i t h  a  h y p o t h e t i c a l  t r o p h i c
capacity. Improper use of oxygen persists in this immune
phase and is also associated with enzymatic stress. Fur-
thermore, lymphatic circulation plays a major role while
macrophages and dendritic cells migrate to lymph nodes
where they activate lymphocytes. As a result, tissues and
organs adopt an leukocytic phenotype [12,13].
Angiogenesis characterizes the last or endocrine phase
of the inflammatory response, during which nutrition
mediated by the blood capillaries is established. However,
the angiogenic process becomes active early and exces-
sive proliferation of endothelial cells takes place which, in
turn, develops a great density of endothelial sprouts [14].
Though this initial and excessive proliferation, the
endothelial cells could successively perform antioxidant
and antienzymatic functions. These functions would
favor the evolution of the inflammatory response towards
tissue repair through specialized capillary development.
Then, it would be in this last phase of the inflammatory
response when the process of angiogenesis would be
responsible for tissue nutrition through capillaries. Oxy-
gen and oxidative metabolism are an excellent combina-
Figure 1 Ischemia/Reperfusion phenotype. Schematic representation of the Pathological Nervous Response in the severe traumatized patient.Aller et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2010, 18:27
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tion through which cells can obtain abundant energy
(energetic stress) for tissue repair by regeneration or
wound healing. As a result, tissues and organs adopt an
angiogenic phenotype [13,14].
The sequence in the expression of progressively more
elaborated and complex nutritional systems could hypo-
thetically be considered the essence of the inflammation
regardless of its etiology (traumatic, hypovolemic or
infectious) or localization. Therefore, the incidence of
harmful influences during their evolution could involve
regression to the most primitive trophic stages, in which
nutrition by diffusion (ischemia-reperfusion phenotype)
takes place. Moreover, the incidence of noxious factors
during the evolution of the systemic inflammatory
response produces severe hemodynamic alterations
again, and lastly vasodilatory shock, with tissue hypoxia,
hypothermia and acidosis, is established. This mecha-
nism of metabolic regression is simple, and also less
costly. It facilitates temporary survival until a more favor-
able environment makes it possible to initiate more com-
plex nutritional ways to survive (leukocytic and
angiogenic phenotypes) [12,13].
Phases of the metabolic response to the injury
Severe injury induces a systemic inflammatory response
in the body that could be developed through the expres-
sion of three successive phenotypes: Ischemia-reperfu-
sion phenotype, leucocytic phenotype and angiogenic
phenotype. In turn, it has already been proposed that
these phenotypes could represent the expression of
trophic functional systems of increasing metabolic com-
plexity [12,13]. This hypothetical approach to the mecha-
nisms that govern the systemic inflammatory response
could be based on the increasing metabolic ability of the
body to use oxygen over the successive phases of its evo-
lution towards the tissue repair. Therefore, in the severe
injury trauma, it could be considered that the body
adapts the support (trophic system) to the metabolic
needs characteristic of each inflammatory phenotype,
regardless of the energy type involved in its production
(mechanical, thermic, electric or nuclear). In turn, the
metabolic ability of each phenotype would be determined
by the mechanisms used for cellular energy production.
Metabolism related to Ischemia-Reperfusion phenotype
This phenotype would characterize the immediate or
nervous phase of the systemic response to the injury. The
nervous alterations in this phase, both sensitive (sensa-
tion of stress, inflammatory pain and analgesic response)
and motor (contraction and relaxation) predominate. The
latter alterations would correspond to both the myocar-
dium (arrhythmias, cardiac arrest), and either the skeletal
or voluntary muscle (fight-or-flight response, withdrawal
reflexes, loss of motor function) or the smooth involun-
tary muscle (vasoconstriction with ischemia-reperfusion)
related to vasodilation, shock and reperfusion injury [13].
A common pathogenic mechanism of this neuromus-
cular response would be the sudden alteration of cellular
membrane potential with depolarization. Thus, there is
increasing evidence that conditions characterized by an
intense local or systemic inflammatory response are asso-
ciated with abnormal ion transport [15]. Early and patho-
logical changes in ion transport in neuromuscular cells
could therefore initiate the inflammatory response. In
addition, disturbances of ion transport have been associ-
ated with intra and extracellular edema [13,15] (Figure 2).
It has been proposed that both cellular as well as inter-
stitial edema could represent an ancestral mechanism to
feed cells by diffusion [12,13]. Consequently small fluctu-
ations in cell hydration can act as separate and potent sig-
nals for cellular metabolism and gene expression. Most
importantly, cell volume changes can be secondary to
cumulative substrates and hormones uptake [16]. Based
on this idea, activation of the hypothalamic-pituitary-
adrenal axis and the adrenomedullary system with gluco-
corticoid secretion and release of epinephrine into the
circulation, which occurs in the early evolutionary period
[17], causes the selective accumulation of these sub-
stances in the interstitial space of the tissues and organs
that suffer ischemia-reperfusion because their endothe-
lial permeability is increased [13].
In this initial phase of the inflammatory response, it
could be considered that hypometabolism, anaerobic gly-
Figure 2 Cellular phenotype of Ischemia/Reperfusion. When this 
phenotype is expressed it produces a body hydroelectrolitic redistribu-
tion. Thus, cellular and interstitial edema is developed. a: Sodium-Po-
tassium pump. b: Calcium-ATPase pump.Aller et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2010, 18:27
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colisis with lactate production, low temperature and a
decrease in energy expenditure could be related to a
primitive cellular trophic mechanism that may be favored
by neuro-endocrine stress-response substances. Interest-
ingly enough, the functional impotence of the somatic
motor system, which controls voluntary movements,
favors blood stasis and interstitial edema [13].
The edema associated with a depression of the metabo-
lism has been termed by David Cuthbertson, as the "ebb
phase" [6,18]. This phase is characterized by hemody-
namic instability [19] and is described in classical litera-
ture on trauma as the period of shock [6].
The direct mitochondrial inhibition by nitrogen and
oxygen species coupled with reduced hormonal stimula-
tion and decreased positive feedback from decreased
metabolic demands all combine to reduce energy produc-
tion. It is supposed that through this mechanism the
affected cells enter in a dormant stage analogous to hiber-
n a t i o n  o r  a e s t i v a t i o n  [ 2 0 ] .  T h a t  i s  w h y  t h i s  m e t a b o l i c
pathway is considered a potentially protective mecha-
nism because the reduced cellular metabolism could
increase the chance of survival of cells, and thus organs,
in the face of an overwhelming injury [20].
Hibernation is considered to be a retained ancestral
trait in modern mammals. Whether hibernation is inher-
ited or a newly developed trait, the widespread distribu-
tion of mammalian species that hibernate suggest that the
genes required to specify the hibernating phenotype are
common among the genomes of all mammals [21].
Therefore "cell hibernation" or "cell stunning" during
ischemia could be a situation of dedifferentiation, with an
intention to adapt to the imposed changes. In this situa-
tion specialized functions would not be expressed,
although primitive metabolic pathways and the corre-
sponding primitive trophic functions would be main-
tained [13].
In essence, the objective of the alterations produced
during the expression of the ischemia-reperfusion pheno-
type could be to induce the highest metabolic autonomy
of tissues and organs. Thus, the swollen interstitial space
would become the storage area for those substances that
are suddenly released into the blood circulation during
the response to stress [7]. In this way, raised blood con-
centrations of catecholamines and stress hormones, such
as cortisol [7,17,22] and glucagon [23], growth hormone
and prolactine [24], glucose and glycolytic intermediates
i.e. lactate and piruvate [6], triglycerides, free fatty radi-
cals and glycerol [6,24], amino acids as alanin, nitrogen
[8,25] and sulphur [6,25] have been described. These sub-
stances stored in the interstitial space would facilitate the
survival of the hypofunctional cells, allowing for their
metabolic autonomy, so a normal state can be restored.
Anoxic environments have occurred throughout the
Earth's history. The anoxic atmosphere of the primitive
earth probably contained water vapor, N2, H2, hydrogen
sulfide (H2S), CO, CO2, HCN and CH4. However, as the
level of O2 increased, so did the toxic effects of its one-
electron reduction products, its highly reactive singlet
reached proportions that made the development of effi-
cient scavenging and protection systems necessary[26].
Sulfhydryl compounds (H2S, CH3, SH, cysteine, glutathi-
one), antioxidants (carotenoids, vitamins C, A and E), an
array of enzymes (catalase, superoxide dismutase, peroxi-
dases) and thiol-rich proteins (thioredoxin, glutaredoxin)
all became necessary as defenses against damage by reac-
tive oxygen and nitrogen species [26]. H2S must have
been the predominant antioxidant early in prokaryotic
evolution [26,27].
Perhaps, by knowing these precedents it is not surpris-
ing that H2S may play a beneficial role in conditions asso-
ciated with the increased generation of reactive oxygen
and nitrogen species [28]. In particular H2S may be useful
to prevent damage associated with hypoxia. Therefore
mice exposed to H2S enter into a physiological state simi-
lar to that observed when animals initiate hibernation,
daily torpor or aestivation, that allows them to endure
periods of low metabolic rate and decreased core body
temperature without apparent ill effects [29,30].
After a severe injury the cardiovascular response can
move from cardiac arrest to shock. Since cardiac arrest is
an evolutive injury, it has been suggested that the optimal
treatment is phase-specific and includes: The electrical
phase (0-4 minutes), the circulatory phase (4-10 minutes)
and the metabolic phase (beyond 10 minutes after cardiac
arrest) [31]. In any case, early initiation of cardiopulmo-
nary resuscitation is the most effective measure [32].
However, other metabolic, i.e. hypothermia, and bio-
chemical interventions, are likely to be effective in the
metabolic phase of cardiac arrest. Two complementary
ways to cover the management of the metabolic phase of
cardiac arrest are considered. The first phase consists in
reducing the adverse effects of metabolic cardiac arrest
promoting basic research on prolonged global whole-
body ischemia. The second phase aims at diminishing the
tissue injury from reperfusion related to cardiopulmo-
nary resuscitation, studying the optimal metabolic condi-
tions of reperfusion, i.e. restoring oxygen and substrates
[31].
S h o c k ,  r e g a r d l e s s  o f  e t i o l o g y ,  i s  c h a r a c t e r i z e d  b y
decreased delivery of oxygen and nutrients to the tissues.
Our therapeutic interventions are directed toward
reversing the cellular ischemia and preventing its conse-
quences [33,34]. Reperfusion injury starts with the simple
reoxygenation of tissues after ischemic insult [35]. Dam-
age control resuscitation [33-36] and damage control sur-
gery [36-39] are used in this early evolutive phase, in
accordance with the patient's physiologic tolerance [39].Aller et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2010, 18:27
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The principles of damage control have led to improved
survival and have stopped bleeding until the physiologic
derangement has been restored and the patient could
undergo a prolonged operation for definitive repair [5,36-
38]. Damage control avoids the "lethal triad" of hypo-
thermia, acidosis and coagulopathy resulting in a vicious
cycle that often cannot be interrupted [39,40].
It is currently accepted that the pathophysiological pro-
cesses in the first days after injury seem to be important
for the development and final outcome in patients with
early multiple organ failure [41]. That is why reducing ini-
tial damage caused by the ischemia and/or the reperfu-
sion would determine a more favorable evolution.
Therefore, the two-hit hypothesis for the development of
multi-organ dysfunction syndrome has been described to
be caused either by the first hit, including organ and soft
tissue injuries, as well as hypoxia and ischemia, or later
due to a second or multiple hits, such as ischemia-reper-
fusion or surgical procedures [4,38,42].
Oxygen deprivation is an important determinant of cel-
lular function during the expression of the ischemia-rep-
erfusion phenotype [43]. The transcriptional response to
hypoxia relies on multi-protein complexes to regulate
several transcription factors, the best studied being
hypoxia inducible factor (HIF). HIF is a heterodimer
which enhances the expression of hypoxia responsive
genes and therefore allows improved cell survival in situ-
ations of limited oxygen availability [43-45]. As a result,
injured cells could turn to glycolisis to meet their ener-
getic demands in hypoxia. Although glycolisis is less effi-
cient than oxidative phosphorylation for producing ATP,
the presence of sufficient glucose can sustain ATP pro-
duction due to increased activity of glycolytic enzymes
[46].
Post-traumatic hyperglycemia induced by cate-
cholamines, among other factors, [6,19] would also favor
the selective support of glucose and therefore the "glyco-
lytic switch" in order to obtain ATP. In turn, glycolytic
metabolism end products, i.e. pyruvate and oxaloacetate,
can promote HIF-1α protein stability and activate HIF-1
inducible gene expression [45]. In addition to impairing
cellular energy metabolism, hypoxia leads to differentia-
tion inhibition and maintains the undifferentiated cell
state [47].
Furthermore, the excess production of reactive oxygen
and nitrogen species in this phase would cause oxidative
stress, which would in turn result in bond cleavage and
lipid and protein molecular breakdown, whose final
products would become substrates in cases of extreme
need [12,13]. Lastly, oxidative stress is one of the princi-
pal factors inducing the expression of the nuclear factor
Kappa B (NF-κB) [44].
Tissue reoxygenation is mediated by oxygenase. In par-
ticular, carbon monoxide (CO) is one of the three prod-
ucts of heme degradation by heme oxygenase (HO)-1.
Essentially nothing is known about local concentrations
of CO that are achieved in vivo and whether that CO pro-
duced endogenously has a therapeutic effect [48].
Another gas, nitric oxide (NO), has been involved as a tis-
sue protective agent during ischemia-reperfusion. NO
seems to protect cells by attenuating the oxidant stress
that occurs during ischemia by inhibiting an oxidase sys-
tem initiated during ischemia which becomes amplified
during the reperfusion phase. In addition, NO can lessen
oxidative injury by scavenging reactive oxygen molecules
[49].
Resuscitation is related to microcirculatory distress.
Microcirculatory failure can occur in the presence of nor-
mal or supranormal systemic hemodynamic- and oxygen-
derived variables, with microcirculatory distress being
masked from the systemic circulation by shunting path-
ways [50]. In particular, splanchnic microcirculatory dys-
function can produce gastrointestinal tract hypoxia or
dysoxia, a state in which the O2 supply is inadequate to
meet tissue metabolic needs [51]. So, by the great vulner-
ability of splanchnic blood flow [52], the first hit, usually
ischemia, results in a gastrointestinal tract priming, ren-
dering it more susceptible to a secondary challenge i.e.
reoxygenation, that stimulates an inappropriate inflam-
matory response [53]. Therefore, the changes in the intes-
tinal microcirculation are in concert with the "two-hit"
theory for multiple organ failure [53,54], which would at
the same time confirm the proposal by Metchnikoff that
the engine behind multiple-organ-failure syndrome is the
gastrointestinal tract [55].
Metabolism related to leukocytic phenotype
This phenotype would characterize the intermediate or
immune phase of the systemic response to the injury. In
this phase the tissues and epithelial organs, which have
previously suffered ischemia-reperfusion, are infiltrated
by inflammatory cells and bacteria. This infiltration
occurs in an edematous oxygen-poor environment [13].
In these tissues and organs, which show oxidative and
nitrosative stress, symbiosis of the inflammatory cells and
bacteria for extra- and intra-cellular digestion could be
associated with a hypothetical trophic capacity [12,13]
which is why their metabolic autonomy would persist in
this phase.
The metabolic response to injury in this immune phase
of the inflammatory response is characterized by hyper-
catabolism and hypermetabolism [8,19,24,56]. This phase
corresponds to the post-shock catabolic response or
hypermetabolic flow phase of Cuthbertson [6,18,23].
The hypermetabolic response after a severe injury has
been described as a hyperdynamic response with
increased body temperature, oxygen and glucose con-
sumption, CO2 production, glycogenolysis, lipolysis, pro-Aller et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2010, 18:27
http://www.sjtrem.com/content/18/1/27
Page 6 of 12
teolysis and futile substrate cycling [18,23,24,56-58]. The
consequences of hypermetabolism are a great loss of
body weight associated with a tremendous loss in essen-
tial body structures [58].
However, hypermetabolism is further associated with
immunologic [2,4,38,59] and endocrinologic responses
[2,59,60]. The immuno-inflammatory response is initi-
ated immediately following injury and is mainly regulated
by cytokines, which act as communication mediators
between leukocytes, bridging the innate and adaptive
immune response [38]. The immune response leads to
systemic inflammatory response syndrome or SIRS, fol-
lowed by a period of recovery mediated by counter-regu-
latory anti-inflammatory response (CARS) [2,4,38,59,61].
Activated phagocytes, i.e. granulocytes and monocytes,
would require anaerobic glycolysis as the main source of
ATP for their functions [62]. This suggests that activated
leukocytes are able to metabolically adapt to the hypoxic
environment in this evolutionary phase of inflammation.
Thus, it was shown that HIF-1α is essential for the upreg-
ulation of enzymes of the glycolytic pathway to supply
phagocytes with enough levels of ATP [62]. Also the oxi-
dative burst is part of the physiological function of phago-
cytes connected to massive production and release of
reactive oxygen species and respiratory burst [63]. Inabil-
ity of the mitochondria to use oxygen due to the uncou-
pling of the electron chain transport is a focus of ongoing
research [35] (Figure 3).
Depression of leukocyte mitochondrial respiration sec-
o n d a r y  t o  t h e  d e c r e a s e  i n  o x y g e n  m e t a b o l i s m  c o u l d
induce obtaining energy by other mechanisms. For exam-
ple, phagocytes could generate sufficiently reduced nico-
tinamide dinucleotide phosphate (NADPH) for their
biological functions, through the continuous replenish-
ment of Krebs cycle intermediates [64]. Through these
anaplerotic mechanisms, phagocytes could obtain suffi-
cient energy not only for the new functions acquired but
also for proliferation. These mechanisms, similar to those
used by cancer cells, would also allow leukocytes to main-
tain a metabolic phenotype of biosynthesis aside from the
normal physiological constrains and therefore, would
acquire an increased metabolic autonomy [65].
Based on this metabolic similarity to cancer cells, glu-
tamine, the most abundant amino acid in mammals,
could be used to replenish the tricarboxylic acid cycle of
leukocytes during this immune phase of the systemic
inflammatory response [64]. It would then be explained
that the administration of this non-essential amino acid
induces an immunoestimulatory effect [38] in these
severe injured patients with a marked acute and pro-
longed depletion of intracellular glutamine [66]. Thus,
NF-κB is known to be a redox sensitive transcription fac-
tor with regard to the production of pro-inflammatory
molecules including chemokines, cytokines and adhesion
molecules, which allow leukocytes to attach themselves
to the endothelium and facilitate their extravasation to
the interstitial space of tissues and organs [35,67].
The metabolic autonomy of leukocytes would also be
reflected in its ability for pro-opiomelanocortin (POMC)
production [64]. POMC is processed in the anterior lobe
of the pituitary gland into an N-terminal fragment, corti-
cotropin (ACTH) and β-lipotrophic hormone (LPH),
while the intermediate lobe produces γ-melanocyte-stim-
ulating hormone (MSH), α-MSH, corticotropin-like
intermediate lobe peptide (CLIP), γ-lipotropin (LPH) and
β-endorphin. An interesting aspect of leukocyte POMC
production is that, while the same peptides are produced
as in the pituitary, the pattern varies, and some are
unique to leukocytes [68].
Corticotropin releasing factor (CRF), which is released
from the hypothalamus during stress, is also produced by
leukocytes and within its action, pro-inflammation,
through the enhancement of the NF-κB intracellular sig-
naling pathway, stands out [69].
Immune cells are also considered a new, diffusely
expressed adrenergic organ, and they have the ability to
generate release and degradate catecholamines. It seems
that catecholamines use intracellular oxidative mecha-
nisms to exert autoregulatory functions on immune cells
[70]. The physiological counterpart of the adrenergic sys-
tem, the cholinergic system, is also known to be an inte-
gral part of human macrophage and lymphocyte
Figure 3 Cellular Leukocytic Phenotype. Adhesion molecules are 
overexpressed on the cells surface favoring the leukocytes and bacte-
ria translocation. a: L-Selectin; b: P-Selectin; c: E-Selectin; d: Integrin; e: 
HLA-Class I molecule; f: HLA-Class II molecule; g: HLA-Class II receptor; 
h: Immunoglobulin.Aller et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2010, 18:27
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regulation and is termed the "cholinergic anti-inflamma-
tory pathway". In this pathway, the efferent activity in the
vagus nerve releases acetylcholine (ACh), which interacts
specifically with macrophage α7  subunits of nicotinic
ACh receptor, leading to cellular deactivation and inhibi-
tion of pro-inflammatory cytokine release [71]. There-
fore, leukocytes through their neurohormonal capacity
could modulate the immunological response inducing
even hyperinflammation or inmmunoparalysis
[2,61,72,73]. In essence, leukocytes seem to become a
peripheral neuroendocrine system, with autocrine and
paracrine functions. This would constitute an alternative
to the central neuroendocrine system, with a predomi-
nantly endocrine function, represented by the hypotha-
lamic-pituitary-organ hormonal axes. These are
suppressed in prolonged critical illness and contribute to
the general wasting syndrome [74,75] (Figure 4).
The immune response underlying the expression of the
leukocyte phenotype could also have a gastrointestinal
origin. The gastrointestinal tract mucosa contains the
largest reservoir of macrophages in the body. As effecter
c e l l s,  i n t e s t i n a l  m a c r o p h a g e s,  t o g e t h e r  w i t h  m a s t  c e l l s,
are first-line defense mechanisms [76]. If this defense
capacity is overtaken, the intestine in the critically ill sur-
gical patient becomes an "undrained abscess" [77] and the
pathological gastrointestinal colonization is associated
with the development of infection and sepsis with late
multi-organ failure [78]. Also, during the expression of
this immune response, the lymphatic splanchnic circula-
tion would acquire increasing importance [79,80]. There-
fore, the expression of the leukocyte phenotype in the
intestine could possibly change this organ into the most
important peripheral autonomous neuroendocrine sys-
tem, in view of the large accumulation of leukocytes with
metabolic autonomy and neuroendocrine capacity.
Metabolism related to angiogenic phenotype
This phenotype would characterize the late or endocrine
phase of systemic response to injury. In this phase, a
return to the prominence of oxidative metabolism would
be produced, and therefore angiogenesis, in the affected
tissues and organs to create the capillary bed that would
make regeneration possible or to carry out repair through
fibrosis or scarring [12,13].
The endocrine functional system facilitates the arrival
of oxygen transported by red blood cells and capillaries. It
is considered that angiogenesis characterizes this last
phase of the inflammatory response, in which nutrition
mediated by the blood capillaries is established. The abil-
ity to use oxygen in the oxidative metabolism is restored
when patients recover their capillary function and, as a
result, nutrition mediated by the capillaries is also
restored (endocrine or late phase).
This type of metabolism is characterized by a large pro-
duction of ATP (coupled reaction) which is used to drive
multiple specialized cellular processes with limited heat
generation that would induce the onset of healing. In the
convalescent phase, the previous dedifferentiated epithe-
lia specializes again, the energy stores that supplied the
substrate necessary for this demanding type of metabo-
lism are replenished, and complete performance is
reached, thus making active normal life possible [13,14].
Angiogenesis is defined as the growth of new vessels
from preexisting ones [81]. Although the final objective
of endothelial growth is to form new vessels for oxygen,
substrates and blood cell transport (vascular phase),
other functions could also be carried out before the new
vessels are formed (prevascular phase). In the initial
phases of the inflammatory response, the new endothelial
cells formed could have a function associated with anti-
i n f l a m m a t o r y  e f f e c t s .  T h a t  i s ,  w i t h  a n t i - o x i d a t i v e  a n d
Figure 4 Schematic representation of the neuro-immune-endo-
crine capacity of the leukocytic (L) phenotype. The immune cells 
are considered a new diffusely expressed adrenergic organ as well a 
peripheral neuroendocrine system with autocrine and paracrine func-
tions. In addition, inflammatory mediators released by leukocytes in-
duce a circulatory switch which favors the lymphovenous circulation. 
Lastly, the leukocytic phenotype is associated with enzymatic stress 
and hypermetabolism which, in turn, cause a General Wasting Syn-
drome. v: venous vascular system; ly: lymphatic vascular system; p: pa-
renchymal cells.Aller et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2010, 18:27
http://www.sjtrem.com/content/18/1/27
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anti-enzymatic stress properties, favoring the progression
of the inflammation as well as its resolution [14].
Angiogenesis is critically dependent on vascular
endothelial growth factor (VEGF) action. HIF-1α upregu-
lates a number of factors involved in cytoprotection,
including angiogenic growth factors such as VEGF,
endothelial progenitor cell recruitment via the endothe-
l i a l  e x p r e s s i o n  o f  s t r o m a l - d e r i v e d  f a c t o r  S D F - 1 ,  H O - 1
and erithropoietin [82]. Furthermore, VEGF promotes
monocyte chemotaxis and the expression of adhesion
molecules [43]. Also, when this last phase of inflamma-
tion begins, macrophages and lymphocytes become the
predominant cell types within the injured tissue. Mac-
rophages, in particular, adopt a potentially angiogenic
phenotype [83-85]. Moreover, peripheral blood mononu-
clear cells can be differentiated into monocytes, lympho-
cytes and endothelial cells. Therefore, endothelial
progenitor cells in the circulation may promote neoan-
giognesis and produce the spontaneous regeneration of
the endothelium in the injured tissue [86].
In contrast to their role in promoting inflammation, the
ability of alarmins to promote tissue repair and regenera-
tion is of increasing interest. Importantly high mobility
group box-1 (HMGB-1) induces migration of stem cells
towards inflamed regions to promote repair and regener-
ation [87]. Furthermore it has the ability to stimulate
angiogenesis. Interestingly enough, many of these restor-
ative effects are mediated through the same receptors
that mediate the pro-inflammatory properties of the mol-
ecule [88].
Obviously, the mechanisms that promote tissue struc-
ture and function restoration also include the mecha-
nisms involved in the resolution of inflammation [89]. In
particular endogenous pro-resolving lipid mediators, i.e.
lipoxins, resolvins and protectins, have been the most
studied [88,89]. In essence, pro-resolution factors revert
back to the pro-inflammatory phenotype to its prior
physiological state and therefore the microcirculatory
functions of tissues and organs return to homeostasis
[90].
Nutrition mediated by blood capillaries is established
because of angiogenesis. The new functional properties
of microcirculation include the exchange of oxygen,
nutrients and waste products. This oxygen support
induces oxidative metabolism, an efficient method for
extracting energy from food molecules, which begins
with the Krebs cycle and ends with oxidative phosphory-
lation [12,13]. Oxygen and oxidative metabolism are an
excellent combination through which cells can obtain an
abundant energy supply (energetic stress) for tissue repair
by specialized cells [12]. Nonetheless, little is known
about the capacity of eukaryotic cells to monitor the
redox state for supporting specialized functions [91].
Although NF-κB acts mainly as an initiator of inflamma-
tion, recent studies suggest that it also functions in the
equally complex process of resolution of inflammation
[92] (Figure 5).
In this convalescence phase, the hypercatabolic syn-
drome is progressively downregulated with the reduction
of catabolic hormones and/or molecules (eg. cate-
cholamines, pro-inflammatory cytokines, cortisol, gluca-
gon) and the increase of anabolic hormones (eg. insulin,
growth hormones, insulin-like growth factor-1 or ana-
bolic steroids) [74,93] that are supported by tissues and
organs through the new vessel arrangement and mor-
phology. Consequently, this anabolic response counter-
acts catabolic stimuli and reverses muscular, both skeletal
and cardiac, wasting and impaired energetic metabolism
with its consequent functional damage [93]. Clinical
studies in recent years have supported the concept of
"immunonutrition" for severely injured patients, which
takes into account the supplementation of omega-3 fatty
acids and essential amino acids, such as glutamine [94].
The progressive recovery of the hypothalamic central-
ization of the autonomous neurofunctions (sympathetic
and vagal nervous system) and endocrine (hypothalamic-
pituitary-organ-hormonal axes) possibly correspond to
the progressive remodeling of the tissues and organs con-
trolled by hemodynamic and metabolic stimuli. On the
contrary, leukocytes during the transition to resolution
would progressively inhibit the neuroendocrine func-
tional capacity found in the previous phases [68-70]. In
turn, they would modulate this last phase of the inflam-
matory response when leukocytes express a lymphocytic
phenotype [95]. In particular, regulatory T (Treg) cells
safeguard the tissues restored against autoimmunity and
immune pathology [96].
Figure 5 Cellular Angiogenic phenotype. Angiogenesis favors tis-
sue repair as well as regeneration. a: P-Selectin; b: Integrin; c: Gap-junc-
tion; d: Claudin (tight junction protein); e: desmosome.Aller et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2010, 18:27
http://www.sjtrem.com/content/18/1/27
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The behavior of the gastrointestinal tract under normal
conditions mainly depends on the morphology and func-
tion of its microcirculation. Thus, the trophic function of
the intestine is coupled with the metabolic needs of the
body. In particular lymph vessels in the mucosal and sub-
mucosal layers, or initial lymphatics, recover their ability
to absorb dietary fat and fat soluble vitamins, which are
secreted by entorocytes in the form of lipid particles or
chylomicrons [97,98].
In conclusion, the hypothetical capacity of the body to
involute or dedifferentiate after a severe injury could
mean an effective defense mechanism because it would
make it possible to retrace a well-known metabolic route
to the specialization of the systemic inflammatory
response during the endocrine phase. This specialization
would require the return of the prominence of oxidative
metabolism and angiogenesis in the affected tissues and
epithelial organs to create the capillary bed that would
make the repair possible [12-14].
The need of a metabolic staging after severe trauma
Elaborating a detailed metabolic staging after severe
injury should be a preferential objective today in order to
obtain a correct treatment for these patients. One
requirement would be for the staging system to have a
clinical significance and as a result, for it to allow for
establishing the correct metabolic support.
In the current review, it has been considered that while
the systemic inflammatory response develops after a
severe injury, the body would successively express pheno-
types of increasing metabolic complexity.
The increasing metabolic complexity of the systemic
acute post-traumatic inflammatory response also shares
some similarities with the successive metabolic stages
that eukaryotic cells develop to obtain energy from food
[99]. Therefore, in a first stage (nervous phase) macro-
molecules (polysaccharides, proteins and fats) are broken
down by oxidative stress to smaller molecules (glucose,
amino acids, triglycerides and free fatty acids). Cells with
an ischemia-reperfusion phenotype would base its
metabolism on anaerobic glycolysis [100]. The most
important part of the second catabolic stage would be
headed by enzymatic stress that produces the symbiosis
of the inflammatory cells and bacteria (immune phase)
[101]. Also the cells with leukocytic phenotype could use
anaplerotic precursors (glutamine) to obtain energy
(NADPH production) that would be employed in biosyn-
thesis pathways (cataplerosis). The addition of an oxygen-
requiring stage to the catabolic process provides cells
with successively more powerful and efficient methods
for extracting energy (electron transport chain). The abil-
ity to use oxygen in oxidative metabolism (oxidative
phosphorylation) is recovered when the patients recover
their capillary function (angiogenic phenotype) and
therefore the nutrition mediated by them (endocrine or
late phase). This type of metabolism is characterized by a
large production of ATP (energetic stress) which is used
to drive specialized multiple cellular processes with lim-
ited generation of heat.
Conclusion
The sequence in the expression of metabolic systems that
becomes progressively more elaborate and complex could
be considered the essence of the metabolic evolution of
severe injured patients. In the successive metabolic
switches or metamorphoses that patients undergo, possi-
bly they would retrace a well-known embryonic fetal
route. If this is not properly executed, homeostasis is not
recovered which is why the patient can suffer a post-trau-
matic stress syndrome.
The hypothesis that atmospheric oxygen concentration
affected the timing of the evolution of cellular compart-
mentalization by constraining the size of domains neces-
sary for communications across membranes has been
suggested [102]. Thus, the relatively rapid changes in the
size of the oxygen-rich external domains coincide with
increasing organism complexity. This points towards a
key role in the increase in abundance and size of recep-
tors over time [102] and adds to a growing body of litera-
ture that most recently connects atmospheric oxygen
levels and macroevolutionary changes with the complex-
ity of metabolic networks and cell types [102,103]. There-
fore, a correlation between increased organism
complexity and the development of the use of the atmo-
spheric oxygen could be established [104,105].
In summary, the current review about the metabolic
changes developed in severe injured patients could sug-
gest that a correlation between the different clinical
phases and the corresponding metabolic stages must be
established. In this way, during the Ischemia-Reperfusion
phenotype expression the main objective would be to
reduce the hydroelectrolytic impairments that when
associated with hypometabolism favor cellular dediffer-
entiation. Therefore, controlled hypothermia and anaero-
bic glycolysis would reduce the metabolic needs of the
patients and so it would be possible to diminish the dele-
terious effects related to ischemia-reperfusion. In this
sense, fermentation would be a good metabolic pathway
alternative to obtain enough energy while avoiding exces-
sive hydroelectrolytic exchange across the cellular mem-
branes, particularly in those tissues and organs which are
more prone to this kind of injury, like intestine, kidneys
and lungs [100]. During the leukocytic phenotype, the
priority would be to reduce the expression of adhesion
molecules and their receptors since they would induce
tissue dedifferentiation. In this phase, hypermetabolism
and enzymatic stress stand out. Therefore, it would be
advisable to modulate the anaplerotic leukocytic metabo-Aller et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2010, 18:27
http://www.sjtrem.com/content/18/1/27
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lism to avoid uncontrolled cellular and bacterial prolifera-
tion. In addition, the early administration of enteral
nutrition and the activation of the antienzymatic acute
phase response would be very useful anti-inflammatory
therapeutic options for severely injured patients in this
evolutive phase. Finally, in the late phase associated with
the angiogenic phenotype expression, probably the best
measure would be the activation of the oxidative metabo-
lism to prioritize cellular specialization with respect to
proliferation. In this way, modulating angiogenesis can
improve the epithelial regeneration of the injured organs,
i.e., gastrointestinal tract, lungs, kidneys and liver, while
avoiding the fibrotic sequelae.
One of the key challenges in future research in this clin-
ical area would be to improve the knowledge about the
exact pathophysiological mechanisms involved in the
successive metabolic phenotypes described since ancient
times as characteristic of the severely injured patients
evolution. However, maybe this objective is not simple
because the behavior of both normal and pathological
organs and tissues are heterogeneous. Therefore, it would
be necessary to study the metabolic relationships which
are established between the different organs of the body
when they suffer a severe injury. Then, the use of more
organ-specific metabolic therapeutic measures would be
more appropriate in the future.
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